Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
Lixue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Cao(Shandong Provincial Hospital), Dan Cui(Harbin Medical University), Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiang Ren(Air Force Medical University), Hui Zhang(Capital Medical University), Yimin Wang(Ministry of Education of the People's Republic of China), Jianwei Wang(Zhejiang Cancer Hospital), Xia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinming Wang(Anhui Medical University), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueyang Zhang(Tsinghua University), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingchuan Zhong(Chinese Academy of Medical Sciences & Peking Union Medical College), Lianhan Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Liu(China-Japan Friendship Hospital)
Cited by 609
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k